Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20180405001Not yet recruiting
Open-label trial of levetiracetam (2 arms), sponsored by All Research. Primary endpoints: Cmax at 48 hours, AUC0-t at 48 hours and 1 more. Planned start Jun 2018; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20180405001.